New hope for steroid users: drug may prevent stomach pain
NCT ID NCT05946135
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested whether the drug fexuprazan can prevent or control stomach inflammation (gastritis) in people who need to take systemic steroids for at least 4 weeks. 42 adults with respiratory diseases were randomly assigned to take either fexuprazan or the standard drug lansoprazole daily. After 4 weeks, researchers compared changes in gastritis symptoms between the two groups.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GASTRITIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Severance Hospital
Seoul, South Korea
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- New gastritis drug candidate tested in three formulations to find the best acid controller
- New gastritis pill faces off against standard treatment in 470-Patient trial
- Simpler h. pylori treatment could reduce antibiotic use
- Gastritis drug showdown: which version works better?
- Gum bacteria linked to stomach troubles? small study investigates
- 120,000-Person study hopes to crack the code of chronic illness